Insider trading

Period: 120 months Stock: ENTA Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

45 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

45 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

45 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

45 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
45 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
45 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

45 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
5 Dec 2025
Or Yat Sun Chief Scientific Officer
Sold at will
$34.01K 2,390 at 14.23
0.6%
Not planned
5 Dec 2025
Kieffer Tara Lynn Chief Product Strategy Officer
Sold at will
$29.97K 2,106 at 14.23
6.4%
Not planned
5 Dec 2025
Luu Brendan Chief Business Officer
Sold at will
$19.84K 1,394 at 14.23
3.5%
Not planned
5 Dec 2025
Rottinghaus Scott T. Chief Medical Officer
Sold at will
$11.36K 798 at 14.23
3.5%
Not planned
5 Dec 2025
Trout Harry R. III See Remarks
Sold at will
$7.71K 542 at 14.23
3.2%
Not planned
5 Dec 2025
Capps Kathleen S. See Remarks
Sold at will
$4.60K 323 at 14.23
3.7%
Not planned
2 Dec 2025
Trout Harry R. III See Remarks
Sold at will
$5.30K 380 at 13.96
2.2%
Not planned
2 Dec 2025
Capps Kathleen S. See Remarks
Sold at will
$2.89K 207 at 13.96
2.3%
Not planned
6 Dec 2024
MELLETT PAUL J Chief Fin. & Admin Officer
Sold on a plan
$20.88K 2,591 at 8.06
2.7%
Planned (10b5-1)
6 Dec 2024
Or Yat Sun Chief Scientific Officer
Sold on a plan
$20.88K 2,591 at 8.06
0.7%
Planned (10b5-1)
6 Dec 2024
Kieffer Tara Lynn Chief Product Strategy Officer
Sold on a plan
$18.40K 2,283 at 8.06
7.2%
Planned (10b5-1)
6 Dec 2024
Luu Brendan Chief Business Officer
Sold on a plan
$18.40K 2,283 at 8.06
6.0%
Planned (10b5-1)
6 Dec 2024
Rottinghaus Scott T. Chief Medical Officer
Sold on a plan
$6.98K 866 at 8.06
4.6%
Planned (10b5-1)
15 Jul 2024
Rottinghaus Scott T. Chief Medical Officer
Sold on a plan
$91.81K 5,375 at 17.08
19.8%
Planned (10b5-1)
12 Jul 2024
Rottinghaus Scott T. Chief Medical Officer
Sold on a plan
$34.16K 2,271 at 15.04
9.5%
Planned (10b5-1)
11 Jul 2024
Rottinghaus Scott T. Chief Medical Officer
Sold on a plan
$64.79K 4,299 at 15.07
15.2%
Planned (10b5-1)
17 Jun 2024
Kieffer Tara Lynn Chief Product Strategy Officer
Sold on a plan
$89.59K 7,266 at 12.33
18.3%
Planned (10b5-1)
5 Dec 2023
Or Yat Sun Sr. VP, R&D & CSO
Sold at will
$23.23K 2,412 at 9.63
0.6%
Not planned
5 Dec 2023
Gardiner Nathaniel S. Sr. VP & General Counsel
Sold at will
$23.23K 2,412 at 9.63
3.4%
Not planned
5 Dec 2023
Kieffer Tara Lynn Sr. VP, New Prod. Strat. & Dev
Sold at will
$20.46K 2,125 at 9.63
5.4%
Not planned
5 Dec 2023
Luu Brendan Sr. VP, Business Dev.
Sold at will
$20.46K 2,125 at 9.63
5.5%
Not planned
5 Dec 2023
Rottinghaus Scott T. Sr. VP & CMO
Sold at will
$5.14K 534 at 9.63
2.0%
Not planned
15 Mar 2023
Or Yat Sun Sr. VP & CSO
Sold, plan not stated 2×
$618.96K 13,925 at 44.45
3.6%
4 Apr 2022
Adda Nathalie Sr. VP & Chief Medical Officer
Sold, plan not stated 4×
$2.37M 32,785 at 72.18
48.4%
1 Apr 2022
Adda Nathalie Sr. VP & Chief Medical Officer
Sold, plan not stated 2×
$3.60M 50,559 at 71.23
59.1%
Sold half or more
2 Mar 2022
Adda Nathalie Sr. VP & Chief Medical Officer
Sold, plan not stated
$874.54K 12,481 at 70.07
26.3%
1 Mar 2022
Adda Nathalie Sr. VP & Chief Medical Officer
Sold, plan not stated 2×
$1.71M 24,339 at 70.26
41.0%
11 Jan 2022
Adda Nathalie Sr. VP & Chief Medical Officer
Sold, plan not stated
$879.15K 12,536 at 70.13
27.6%
1 Dec 2021
Adda Nathalie Sr. VP & Chief Medical Officer
Sold, plan not stated 7×
$1.17M 13,523 at 86.35
29.1%
1 Nov 2021
Adda Nathalie Sr. VP & Chief Medical Officer
Sold, plan not stated 3×
$810.42K 9,547 at 84.89
26.2%
11 Oct 2021
Adda Nathalie Sr. VP & Chief Medical Officer
Sold, plan not stated
$284.69K 4,047 at 70.34
13.1%
8 Oct 2021
Adda Nathalie Sr. VP & Chief Medical Officer
Sold, plan not stated
$942.93K 13,453 at 70.09
33.3%
1 Mar 2019
Or Yat Sun Sr. VP & CSO
Sold, plan not stated 2×
$1.04M 10,000 at 103.53
3.2%
13 Feb 2019
Gardiner Nathaniel S. Sr. VP & General Counsel
Sold, plan not stated
$311.56K 3,270 at 95.28
12.0%
12 Feb 2019
Or Yat Sun Sr. VP & CSO
Sold, plan not stated
$567.17K 6,297 at 90.07
2.0%
11 Feb 2019
Or Yat Sun Sr. VP & CSO
Sold, plan not stated 4×
$2.47M 27,684 at 89.39
8.2%
1 Oct 2018
Ocain Tim Senior Vice President
Sold, plan not stated 4×
$2.09M 25,000 at 83.64
80.3%
Sold half or more
20 Sep 2018
Adda Nathalie Sr. VP & Chief Medical Officer
Sold, plan not stated 5×
$396.04K 4,155 at 95.32
100%
Sold half or more
20 Aug 2018
Adda Nathalie Sr. VP & Chief Medical Officer
Sold, plan not stated 4×
$383.60K 4,155 at 92.32
93.1%
Sold half or more
18 Jul 2018
Adda Nathalie Sr. VP & Chief Medical Officer
Sold, plan not stated 4×
$629.84K 5,045 at 124.84
77.0%
Sold half or more
18 Jun 2018
Adda Nathalie Sr. VP & Chief Medical Officer
Sold, plan not stated 3×
$477.22K 4,155 at 114.85
53.6%
Sold half or more
16 May 2018
Adda Nathalie Sr. VP & Chief Medical Officer
Sold, plan not stated 3×
$437.33K 4,155 at 105.25
46.4%
16 Apr 2018
Adda Nathalie Sr. VP & Chief Medical Officer
Sold, plan not stated 2×
$361.56K 4,225 at 85.58
41.3%
4 Jan 2017
Or Yat Sun Chief Scientific Officer
Sold, plan not stated
$488.50K 13,921 at 35.09
4.4%
29 Nov 2016
Or Yat Sun Chief Scientific Officer
Sold, plan not stated
$437.61K 13,921 at 31.44
4.2%
Showing 1–45 of 45.